Aterian, Inc. (NASDAQ:ATER – Get Free Report)’s share price dropped 3.8% during trading on Monday . The company traded as low as $1.24 and last traded at $1.25. 106,227 shares were traded during trading, a decline of 35% from the average daily volume of 164,060 shares. The stock had previously closed at $1.30.
Analyst Upgrades and Downgrades
ATER has been the topic of several recent analyst reports. Weiss Ratings upgraded shares of Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, May 19th. Wall Street Zen upgraded shares of Aterian to a “hold” rating in a report on Saturday, June 27th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.
Get Our Latest Report on Aterian
Aterian Stock Performance
Aterian (NASDAQ:ATER – Get Free Report) last released its earnings results on Friday, May 15th. The company reported ($0.39) EPS for the quarter, topping the consensus estimate of ($0.69) by $0.30. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.The business had revenue of $0.02 million for the quarter, compared to the consensus estimate of $15.82 million.
Institutional Trading of Aterian
Institutional investors have recently bought and sold shares of the company. Susquehanna International Group LLP increased its stake in Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares in the last quarter. Citadel Advisors LLC lifted its stake in shares of Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after buying an additional 22,865 shares in the last quarter. XTX Topco Ltd purchased a new stake in shares of Aterian during the second quarter valued at approximately $55,000. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after buying an additional 9,026 shares during the last quarter. 7.02% of the stock is owned by hedge funds and other institutional investors.
Aterian Company Profile
Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.
Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.
See Also
- Five stocks we like better than Aterian
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.
